1. Venoarterial Extracorporeal Membrane Oxygenation After Autologous Stem Cell Transplantation With Pancytopenia: JACC Patient Care Pathways.
- Author
-
Howick V, James F., Rezkalla, Joshua A., Tilbury, Thomas, Mankad, Sunil V., Bennett, Courtney E., Herrmann, Joerg, Barsness, Gregory, Ansell, Stephen M., and Read, Matthew D.
- Subjects
- *
EXTRACORPOREAL membrane oxygenation , *STEM cell transplantation , *ARTIFICIAL blood circulation , *CARDIOPULMONARY resuscitation , *CARDIAC arrest , *ADVANCED cardiac life support , *PANCYTOPENIA , *CARDIOGENIC shock - Abstract
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary mechanical circulatory support and simultaneous extracorporeal gas exchange for acute cardiorespiratory failure. By providing circulatory support, VA-ECMO gives treatments time to reach optimal efficacy or may be used as a bridge to a more durable mechanical solution for patients with acute cardiopulmonary failure. It is commonly used when a readily reversible etiology of decompensation is identified with very strict inclusion criteria for extracorporeal cardiopulmonary resuscitation use. We present a unique case in which VA-ECMO/extracorporeal cardiopulmonary resuscitation was used after cardiac arrest with pulseless electrical activity in a patient with recurrent lymphoma of the left thigh with recent autologous stem cell transplant. • Coronary interventions and other therapeutic strategies in the setting of malignancy and pancytopenia require individualized, comprehensive, multidisciplinary approaches. • Patients with cancer who survive out-of-hospital cardiac arrest are less likely to receive postresuscitation treatment than patients without cancer. • When there is a potentially reversible cause of acute cardiopulmonary failure, VA-ECMO can provide temporary mechanical support. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF